Melphalan and Filgrastim to Stimulate Peripheral Stem Cells in Patients With Multiple Myeloma
Status:
Completed
Trial end date:
2003-06-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Melphalan and colony-stimulating factors such as filgrastim may increase the
number of immune cells found in bone marrow or peripheral blood.
PURPOSE: Phase II trial to study the effectiveness of melphalan combined with filgrastim in
stimulating peripheral stem cells in patients who have multiple myeloma.